Recent News

• 06.11.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
• 06.11.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
• 05.30.2025 - Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid Cancers
• 05.30.2025 - Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid Cancers
• 05.30.2025 - Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid Cancers
• 05.28.2025 - Adaptive Biotechnologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
• 05.28.2025 - Adaptive Biotechnologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
• 05.28.2025 - Adaptive Biotechnologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
• 05.01.2025 - Adaptive Biotechnologies First Quarter Financial Results
• 05.01.2025 - Adaptive Biotechnologies First Quarter Financial Results

Recent Filings

• 05.20.2025 - 4/A Statement of changes in beneficial ownership of securities
• 05.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 05.07.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.01.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.01.2025 - 144 Report of proposed sale of securities